The research team is the first to perform virtual clinical trials using a multi-scale lung model, with early results expected next year, to examine this reemerging global health threat.

New autoimmune disorder research may provide clues as to why TNF inhibitors, the drugs used to treat these diseases, carry serious infection and cancer risks.